Nuclear BCL10 in primary Sjögren's syndrome

Journal of Oral Pathology and Medicine

Volumn 38, Issue 6, 2009, Pages 501-507

  Gatumu, Margaret K ^a   Jonsson, Malin V ^a   Øijordsbakken, Gunnvor ^a   Skarstein, Kathrine ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

BCL10; P65; Sj gren's syndrome

Indexed keywords

COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 10; SYNAPTOTAGMIN I;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; FEMALE; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPHOCYTIC INFILTRATION; LYMPHOMA; MALE; MINOR SALIVA GLAND; PRIORITY JOURNAL; PROTEIN EXPRESSION; SJOEGREN SYNDROME; TONSIL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CELL NUCLEUS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; NF-KAPPA B; RECEPTORS, COMPLEMENT 3D; SALIVARY GLANDS, MINOR; SJOGREN'S SYNDROME; TRANSCRIPTION FACTOR RELA; XEROSTOMIA; YOUNG ADULT;

EID: 67650733107     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00757.x     Document Type: Article

References (35)

1. Jonsson R, Bolstad AI, Brokstad KA, et al. Sjögren's syndrome-A plethora of clinical and immunological phenotypes with a complex genetic background. Ann NY Acad Sci 2007 1108 : 433 47.
2. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006 6 : 205 17.
3. Stott DI, Hiepe F, Hummel M, et al. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome. J Clin Invest 1998 102 : 938 46.
4. Jonsson MV, Szodoray P, Jellestad S, et al. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjögren's syndrome. J Clin Immunol 2005 25 : 189 201. (Pubitemid 40884044)
5. Salomonsson S, Jonsson MV, Skarstein K, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003 48 : 3187 201.
6. Jonsson MV, Skarstein K, Jonsson R, et al. Serological implications of germinal center-like structures in primary Sjögren's syndrome. J Rheumatol 2007 34 : 044 9.
7. Jonsson MV, Skarstein K. Follicular dendritic cells confirm lymphoid organization in the minor salivary glands of primary Sjögren's syndrome. J Oral Pathol Med 2008 37 : 515 21.
8. Allen CDC, Okada T, Cyster JG. Germinal-center organization and cellular dynamics. Immunity 2007 27 : 190 202. (Pubitemid 47284923)
9. Schulze-Luehrmann J, Ghosh S. Antigen-receptor signaling to nuclear factor [kappa]B. Immunity 2006 25 : 701 15.
10. Zhang Q, Siebert R, Yan M, et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 1999 22 : 63 8.
11. Willis TG, Jadayel DM, Du M-Q, et al. Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999 96 : 35 45. (Pubitemid 29044151)
12. Ruland J, Duncan GS, Elia A, et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-[kappa] B and neural tube closure. Cell 2001 104 : 33 42. (Pubitemid 32144970)
13. Arenzana-Seisdedos F, Turpin P, Rodriguez M, et al. Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci 1997 110 : 369 78.
14. Hayden MS, West AP, Ghosh S. NF-[kappa]B and the immune response. Oncogene 2006 25 : 6758 80.
15. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002 61 : 554 8.
16. Ye H, Dogan A, Karran L, et al. BCL10 expression in normal and neoplastic lymphoid tissue: nuclear localization in MALT lymphoma. Am J Pathol 2000 157 : 1147 54.
17. Sagaert X, Laurent M, Baens M, et al. MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells. Mod Pathol 2005 19 : 225 32.
18. Ye H, Gong L, Liu H, et al. MALT lymphoma with t(14;18)(q32;q21)/IGH- MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression. J Pathol 2005 205 : 293 301. (Pubitemid 40253919)
19. Smedby KE, Hjalgrim H, Askling J, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2006 98 : 51 60. (Pubitemid 43057092)
20. Lazarus MN, Robinson D, Mak V, et al. Incidence of cancer in a cohort of patients with primary Sjögren's syndrome. Rheumatology 2006 45 : 1012 5.
21. Theander E, Henriksson G, Ljungberg O, et al. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006 65 : 796 803. (Pubitemid 43799181)
22. Ekstrom Smedby K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008 111 : 4029 38.
23. Barone F, Bombardieri M, Rosado MM, et al. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjögren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. J Immunol 2008 180 : 5130 40.
24. Nakagawa M, Seto M, Hosokawa Y. Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein. Leukemia 2006 20 : 929 36.
25. Remstein ED, Kurtin PJ, Einerson RR, et al. Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1. Leukemia 2003 18 : 156 60.
26. Gallardo F, Bellosillo B, Espinet B, et al. Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma. Hum Pathol 2006 37 : 867 73.
27. Oshiro H, Ebihara Y, Serizawa H, et al. Idiopathic retroperitoneal fibrosis associated with immunohematological abnormalities. Am J Med 2005 118 : 782 6.
28. Drayton DL, Liao S, Mounzer RH, et al. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol 2006 7 : 344 53.
29. Ye H, Gesk S, Martin-Subero JI, et al. BCL10 gene amplification associated with strong nuclear BCL10 expression in a diffuse large B cell lymphoma with IGH-BCL2 fusion. Haematologica 2006 91 : ECR28.
30. Lobry C, Lopez T, Israel A, et al. Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10. Proc Natl Acad Sci USA 2007 104 : 908 13.
31. Bonizzi G, Karin M. The two NF-[kappa]B activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004 25 : 280 8.
32. Dejardin E. The alternative NF-[kappa]B pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem Pharmacol 2006 72 : 1161 79.
33. Kuo S-H, Chen L-T, Yeh K-H, et al. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. J Clin Oncol 2004 22 : 3491 7.
34. Merzianu M, Jiang L, Lin P, et al. Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and does not correlate with p65 NF-kappaB activation. Mod Pathol 2006 19 : 891 8.
35. Talwalkar SS, Valbuena JR, Abruzzo LV, et al. MALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast. Mod Pathol 2006 19 : 1402 8.